Similar CXCL12-mediated fibroimmune mechanisms may be operative in other chronic inflammatory or fibrotic skin diseases such as lichen planopilaris, chronic graft-versus-host disease, or even scleroderma [37,38,39]. The gene discussed is CXCL12; the disease is chronic graft versus host disease.